Chemoprevention and Novel Therapy for Hepatocellular Carcinoma Associated with Chronic Hepatitis B Virus Infection

Overview

Journal Hepatobiliary Surg Nutr

Publisher AME Publishing Company

Date 2014 Feb 27

PMID 24570914

Citations 8

Authors

Ih-Jen Su

Wen-Chuan Hsieh

Hung-Wen Tsai

Han-Chieh Wu

Affiliations

Soon will be listed here.

Citing Articles

Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors.

Yang Z, Guan R, Fu Y, Hu D, Zhou Z, Chen M Front Cell Infect Microbiol. 2024; 14:1336619.

PMID: 38415009 PMC: 10896825. DOI: 10.3389/fcimb.2024.1336619.

HBV-Induced Immune Imbalance in the Development of HCC.

Chen Y, Tian Z Front Immunol. 2019; 10:2048.

PMID: 31507621 PMC: 6718466. DOI: 10.3389/fimmu.2019.02048.

Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Yan P, Wang R, Zhang J, Cong W, Dong H, Yu H J Gastrointest Surg. 2018; 22(5):872-883.

PMID: 29313290 DOI: 10.1007/s11605-017-3638-0.

Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Teng C, Wu H, Shyu W, Jeng L, Su I Cell Transplant. 2017; 26(3):429-438.

PMID: 28195035 PMC: 5657708. DOI: 10.3727/096368916X694382.

Hepatocellular carcinoma and hepatitis B surface protein.

Li Y, Yang F, Lu H, Zhang J World J Gastroenterol. 2016; 22(6):1943-52.

PMID: 26877602 PMC: 4726670. DOI: 10.3748/wjg.v22.i6.1943.

References

Fransvea E, Angelo Paradiso , Antonaci S, Giannelli G . HCC heterogeneity: molecular pathogenesis and clinical implications. Cell Oncol. 2009; 31(3):227-33. PMC: 4619048. DOI: 10.3233/CLO-2009-0473. View

Kwon H, Lok A . Does antiviral therapy prevent hepatocellular carcinoma?. Antivir Ther. 2011; 16(6):787-95. DOI: 10.3851/IMP1895. View

Chisari F, Klopchin K, Moriyama T, PASQUINELLI C, Dunsford H, Sell S . Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989; 59(6):1145-56. DOI: 10.1016/0092-8674(89)90770-8. View

Chisari F, Ferrari C . Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995; 13:29-60. DOI: 10.1146/annurev.iy.13.040195.000333. View

Jiang J, Nilsson-Ehle P, Xu N . Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis. 2006; 5:4. PMC: 1420303. DOI: 10.1186/1476-511X-5-4. View

Chan A, Arber N, Burn J, Chia W, Elwood P, Hull M . Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila). 2011; 5(2):164-78. PMC: 3273592. DOI: 10.1158/1940-6207.CAPR-11-0391. View

Peters J, Shah Y, Gonzalez F . The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer. 2012; 12(3):181-95. PMC: 3322353. DOI: 10.1038/nrc3214. View

Tan A, Yeh S, Liu C, Cheung C, Chen P . Viral hepatocarcinogenesis: from infection to cancer. Liver Int. 2008; 28(2):175-88. DOI: 10.1111/j.1478-3231.2007.01652.x. View

Siegel A, Zhu A . Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009; 115(24):5651-61. PMC: 3397779. DOI: 10.1002/cncr.24687. View

10.

Sitia G, Aiolfi R, Di Lucia P, Mainetti M, Fiocchi A, Mingozzi F . Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci U S A. 2012; 109(32):E2165-72. PMC: 3420192. DOI: 10.1073/pnas.1209182109. View

11.

Yang J, Teng C, Wu H, Tsai H, Chuang H, Tsai T . Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology. 2009; 49(6):1962-71. DOI: 10.1002/hep.22889. View

12.

Ercolani G, Grazi G, Ravaioli M, Del Gaudio M, Gardini A, Cescon M . Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg. 2003; 237(4):536-43. PMC: 1514472. DOI: 10.1097/01.SLA.0000059988.22416.F2. View

13.

Hoshida Y, Nijman S, Kobayashi M, Chan J, Brunet J, Chiang D . Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009; 69(18):7385-92. PMC: 3549578. DOI: 10.1158/0008-5472.CAN-09-1089. View

14.

Kremsdorf D, Soussan P, Paterlini-Brechot P, Brechot C . Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene. 2006; 25(27):3823-33. DOI: 10.1038/sj.onc.1209559. View

15.

Brown A . Viral hepatitis and fatty liver disease: how an unwelcome guest makes pâté of the host. Biochem J. 2008; 416(2):e15-7. DOI: 10.1042/BJ20081916. View